Boston Scientific reports $1.87B in Q2 sales: 5 financial report highlights

Boston Scientific, a medical technology company, has reported its second quarter financial results. Here are five highlights from the report.

1. The company generated $1.873 billion in sales during the second quarter, within its guidance range of $1.840 billion to $1.890 billion.

2. The company demonstrated a 4 percent operation revenue growth, compared to the same period last year.

3. Boston Scientific had an operating cash flow of $286 million and created an agreement to acquire the interventional division of Bayer AG.

4. The company finished the quarter with $333 million in endoscopy sales, compared to $320 million in 2013. Endoscopy was its seventh highest earning category of products.

5. Boston Scientific estimates revenue for the full year will be from $7.3325 billion to $7.425 billion. The company estimates its third quarter results to be in the range of $1.790 billion to $1.840 billion.

More Articles on Gastroenterology:
6 recent GI field partnerships
8 endoscopy center administrators to know
11 gastroenterologists making the news

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months